Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reexamination Certificate
2007-08-21
2007-08-21
Richter, Johann (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C424S046000, C424S043000, C424S489000, C424S434000, C514S573000, C514S253030, C514S638000
Reexamination Certificate
active
10685746
ABSTRACT:
Methods are provided for increasing libido and/or treating erectile dysfunction in a man. The methods include the administration of a formulation testosterone alone, another fast-acting drug to treat erectile dysfunction or a combination of the testosterone and the other drug where at least one is delivered by aersolization. The formulation is preferably aerosolized and inhaled into a patient's lungs where particles of testosterone and/or the fast-acting erectile dysfunction drug deposits on lung tissue and then enter the patient's circulatory system.
REFERENCES:
patent: 4895719 (1990-01-01), Radhakrishnan et al.
patent: 5426107 (1995-06-01), Bell et al.
patent: 5536714 (1996-07-01), Kojima et al.
patent: 5756071 (1998-05-01), Mattern et al.
patent: 5877216 (1999-03-01), Place et al.
patent: 6342251 (2002-01-01), Illum et al.
patent: 6395744 (2002-05-01), Adams et al.
patent: 6579968 (2003-06-01), Blood et al.
patent: 6632419 (2003-10-01), Rubsamen et al.
patent: 6803031 (2004-10-01), Rabinowitz et al.
patent: 2002/0107182 (2002-08-01), Blood et al.
patent: 2003/0119714 (2003-06-01), Naylor et al.
patent: 2004/0081624 (2004-04-01), Nguyen et al.
patent: 2004/0204440 (2004-10-01), Staniforth et al.
patent: 1 097 711 (2001-05-01), None
patent: 06 211675 (1994-08-01), None
patent: WO9428902 (1994-12-01), None
patent: WO97/29735 (1997-08-01), None
patent: WO98/29096 (1998-07-01), None
patent: WO98/31346 (1998-07-01), None
patent: WO98/34595 (1998-08-01), None
patent: WO 00/40226 (2000-07-01), None
S.R.Davis, “The therapeutic use of androgens in women”, Journal od steroid biochemistry and molecular biology 69 (1999), 177-184.
Drug Information Handbook, Lacy et al, LEXi-COMP, Inc. Edition 1993, pp. 867-869.
Drug Facts and Comparison, Drug Information on sildenafil citrate, 1998 (obtained on-line).
S. R. Davis, “The therapeutic use of androgens in women”, Journal of steroid biochemistry and molecular biology 69 (1999) 177-184.
DIALOG® databse—File 351:Derwent WPI: “Non-occlusive, percutaneous, or transdermal drug delivery system—having active agent, safe and approved sunscreen as penetration enhancer, and optional volatile liquid.”.
Ko et al., “Emulsion formulations of testosterone for nasal administration” J. Microencapsulation, 15(2):197-205 (1998).
Edwards et al., “Large Porous Particles for Pulmonary Drug Delivery” Science, 276:1868-1871 (Jun. 20, 1997).
Kaplan et al., “Safety and Efficacy of Sildenafil In Postmenopausal Women With Sexual Dysfunction” Urology, 53 (3):481-486 (1999).
Fava et al., “An Open Trial of Oral Sildenafil in Antidepressant-Induced Sexual Dysfunction” Psychother. Psychosom. 67:328-331 (1998).
Blanchard James
Cole Robert
Linn Lawrence
Rubsamen Reid M.
Schuster Jeffrey
Aradigm Corporation
Bozicevic Karl
Bozicevic Field & Francis LLP
Haghighatian Mina
Richter Johann
LandOfFree
Methods and compositions for treating erectile dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating erectile dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating erectile dysfunction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3874288